Le Lézard
Classified in: Health, Science and technology
Subject: AWD

Damo And BigRio Celebrate The 2023 DigiMtm Digital Maturity Momentum Awards Recipients For Their Excellence and Contribution To Digital Transformation In Healthcare


DigiMtm Digital Maturity Momentum Awards celebrate individuals and organizations that have demonstrated outstanding commitment, innovation, and impact in advancing digital maturity within our industry. This year we also have global participants.

NAPERVILLE, Ill., April 25, 2024 /PRNewswire-PRWeb/ -- Damo, a leading digital transformation advisory firm for healthcare, is thrilled to announce the recipients of the 2023 DigiMtm Digital Maturity Momentum Awards, recognizing excellence and contributions to digital transformation in healthcare. These awards celebrate individuals and organizations that have demonstrated outstanding commitment, innovation, and impact in advancing digital maturity within our industry.

This year we have added an additional - the fifth - dimension to the DigiMtm Digital Maturity Assessment, called AI/GenAI. GenAI is set to transform the world of healthcare by disrupting diagnosis, research, and more.

"I am thrilled to see the progress made by our participants," said Rohit Mahajan, Managing Partner and CEO, Damo. "I am also excited to see the interest expressed by hospitals from regions outside the US."

"Our mission at Intermountain Health is to help people live the healthiest lives possible. Our consumers, patients, members and caregivers are the foundation of our digital strategy. We continually work to simplify to help create industry-leading digital experiences, and guide and empower people to take the next step in their health journeys," says, Craig Richardville, Chief Digital and Information Officer, Intermountain Health.

Dr. Jonathan Welch, MD, Chief Population Health and Chief Innovation Officer, stated, "At Geisinger, we are committed to making better health easier for our community. This recognition is a testament to the work we're investing in to help our patients and community. We believe in innovation, digital engagement, the power of data and will continue to invest in digital capabilities to help us achieve our goals."

In addition, there are individual excellence awards for consumer digital, technology innovation, and AI. "This year we have added an additional - the fifth - dimension to the DigiMtm Digital Maturity Assessment, called AI/GenAI. GenAI is set to transform the world of healthcare by disrupting diagnosis, research, and more."

Leaders who have contributed significantly to the digital transformation journey in healthcare:

Intermountain Health

Geisinger

Virtua Health

United Medical Center

The Digital Maturity Momentum Awards is based on Damo's DigiMtm 5-stage maturity framework that has been standard for health systems looking to assess their maturity and benchmark themselves against peers. The benchmark data from the assessments act as a guide to digital health and technology investment priorities. The Damo team has put together a report on the awardees, along with benchmark data on digital transformation at these organizations.

The complete report on the 2023 DigiMtm Digital Maturity Momentum Awards is available here.

Media Contact

Rohit Mahajan, Damo Consulting, 1 630 242 2881, [email protected], www.damoconsulting.net

Twitter

SOURCE Damo Consulting


These press releases may also interest you

at 07:00
To mark National Hospice Palliative Care Week, the Quebec Coalition for Palliative Care Access (the Coalition) is proud to celebrate the positive impact of palliative care on the well-being of people with life-limiting illness. Palliative care is...

at 06:00
A native born and trained Brazilian oncologist is in the forefront of a new era in the treatment of cancer patients with cutting edge proton therapy medical technology developed in Israel by P-Cure. "It is my dream to be able to bring the P-Cure...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...

4 mai 2024
Women's Heart Health Month is recognized every May and is focused on raising awareness about cardiovascular health among women. It aims to educate women about the risks, symptoms, and prevention of heart disease, which is the leading cause of death...

4 mai 2024
RaySearch Laboratories AB (publ) and C-RAD are pleased to announce a collaboration agreement, aiming at jointly developing innovative solutions and products to enhance the quality of radiation therapy. The focus of the collaboration is to...



News published on and distributed by: